Clinical Trial
4 Apr 2022
JOURNAL：Circulation.
Article Link
Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism after TAVR: The ADAPT-TAVR Randomized Clinical Trial
D-W Park, J-M Ahn, D-Y Kang et al.
KEYWORDS
TAVR; without an indication for long-term anticoagulation; subclinical leaflet thrombosis
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
